Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Ano de publicação
Intervalo de ano de publicação
1.
J Obstet Gynaecol ; 43(1): 2174836, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36795605

RESUMO

HELLP syndrome is a disorder during pregnancy which is defined by elevation of liver enzymes, haemolysis, and low platelet count. This syndrome is a multifactorial one and both genetic and environmental components can have a crucial role in this syndrome's pathogenesis. Long noncoding RNAs (lncRNAs), are defined as long non-protein coding molecules (more than 200 nucleotides), which are functional units in most cellular processes such as cell cycle, differentiation, metabolism and some diseases progression. As these markers discovered, there has been some evidence that they have an important role in the function of some organs, such as placenta; therefore, alteration and dysregulation of these RNAs can develop or alleviate HELLP disorder. Although the role of lncRNAs has been shown in HELLP syndrome, the process is still unclear. In this review, our purpose is to evaluate the association between molecular mechanisms of lncRNAs and HELLP syndrome pathogenicity to elicit some novel approaches for HELLP diagnosis and treatment.


Assuntos
Síndrome HELLP , RNA Longo não Codificante , Gravidez , Feminino , Humanos , Síndrome HELLP/diagnóstico , Síndrome HELLP/genética , RNA Longo não Codificante/genética , Placenta/patologia , Progressão da Doença
2.
Arch Gynecol Obstet ; 284(5): 1157-62, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21165744

RESUMO

PURPOSE: Recent studies indicated that there is a high density of small nerve fibers in the functional layer of the endometrium in women with endometriosis and that it can be used as a marker to detect endometriosis. In this study, the efficacy assessment of small nerve fibers' density as a diagnostic marker was compared in patients with and without endometriosis. METHODS: In this study, women with history of pelvic pain and/or infertility who were candidates for laparoscopy or laparotomy in Rassoul hospital (2007-2009) were enrolled. Histological sections of endometrial tissue were prepared from endometrial biopsy from women with endometriosis (n = 12) (1) and without endometriosis (n = 15) (2). Protein gene product 9.5 and neurofilament were evaluated as marker from endometrial biopsies by immunohistochemical methods. RESULTS: There was no statistically significant difference between two groups according to age, body mass index. Nerve fibers were detected in all endometrial biopsies from all women with endometriosis but detected only in three women without endometriosis. The mean density of nerve fibers was 2.2 ± 4.7 mm(-2) in group without endometriosis and) 13.1 ± 3.3 (in group with endometriosis (p < 0.001). Women with endometriosis had significantly higher nerve fiber density in comparison with women without endometriosis. CONCLUSIONS: Our findings indicated that endometrial biopsy for detecting density of nerve fibers by usage of protein gene product 9.5, provided a reliable marker for diagnosis of endometriosis.


Assuntos
Endometriose/diagnóstico , Endométrio/inervação , Adolescente , Adulto , Biomarcadores/análise , Biópsia , Endometriose/patologia , Endométrio/patologia , Feminino , Humanos , Infertilidade Feminina/diagnóstico , Pessoa de Meia-Idade , Fibras Nervosas/patologia , Proteínas de Neurofilamentos/análise , Dor Pélvica/diagnóstico , Dor Pélvica/patologia , Estudos Prospectivos , Ubiquitina Tiolesterase/análise , Adulto Jovem
3.
Int J Gynaecol Obstet ; 113(3): 192-5, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21457979

RESUMO

OBJECTIVE: To compare the effectiveness and adverse effects of nifedipine versus indomethacin in the treatment of preterm labor. METHODS: In a randomized clinical trial, 79 women with labor pain at 26-33 weeks of gestation were treated with either oral nifedipine (n=40) or rectal indomethacin (n=39). RESULTS: Twenty-three (59%) women in the indomethacin group, and 10 (25%) in the nifedipine group did not respond to treatment (P=0.002). None of the 16 and 30 women remaining in the indomethacin and nifedipine groups, respectively, delivered during the subsequent 48 hours. Of these remaining women, 1 (6.25%) in the indomethacin group and 4 (13.3%) in the nifedipine group delivered between 48 hours and 7 days (P=0.162). For the women who responded to treatment, the mean gestational age at time of delivery was 238.5±19.4 days and 246.4±15.4 days in the nifedipine and indomethacin groups, respectively (P=0.182). Seventeen (42.5%) women in the nifedipine group, and 11 (28.2%) in the indomethacin group showed adverse effects (P=0.184). CONCLUSION: Indomethacin was less effective than nifedipine for the fast treatment of preterm labor. For women who responded to treatment within 2 hours, however, the delaying of delivery by indomethacin was similar to that by nifedipine.


Assuntos
Indometacina/uso terapêutico , Nifedipino/uso terapêutico , Trabalho de Parto Prematuro/tratamento farmacológico , Tocolíticos/uso terapêutico , Adulto , Esquema de Medicação , Feminino , Humanos , Indometacina/administração & dosagem , Indometacina/efeitos adversos , Nifedipino/administração & dosagem , Nifedipino/efeitos adversos , Gravidez , Nascimento Prematuro/prevenção & controle , Tocolíticos/administração & dosagem , Tocolíticos/efeitos adversos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA